8-Hydroxypsoralen; 8-Hydroxypsoralene; Psoralen, 8-hydroxy-; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-hydroxy-; 8-Hydroxyfuranocoumarin; Xanthotoxol (6CI); XANTHOTOL; 9-Hydroxy-7H-furo[3,2-g]chromen-7-one; NSC 401269; 9-Hydroxy-7H-furo(3,2-g)(1)benzopyran-7-one; 9-hydroxyfuro[3,2-g]chromen-7-one; NSC401269; 9-Hydroxy-7H-furo[3,2-g][1]benzopyran-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-hydroxy-; 6,7-Dihydroxy-5-benzofuranacrylic acid gamma-lactone; EINECS 217-923-1; BRN 0189491; 8-hydroxy-psoralen; 8-Hydroxyanthotoxol; 8-hydroxyfurocoumarin; 8-hydroxyfurocoumarins; 9-hydroxy-furo[3,2-g]chromen-7-one; 8-hydroxyfuranocoumarins; an 8-hydroxyfurocoumarin; 7H-Furo[3, 9-hydroxy-; CHEMBL1192; 5-19-06-00014 (Beilstein Handbook Reference); 7H-Furo[3,2-g][1]benzopyran-7-one,9-hydroxy-; MLS002472938; SCHEMBL499269; 5-Benzofuranacrylic acid, 6,7-dihydroxy-, gamma-lactone; DTXSID50173910; HMS2267B05; HMS3886P18; ZINC895404; BDBM50361378; MFCD00017408; s9174; 9-hydroxyfurano[3,2-g]chromen-2-one; AKOS000276803; CCG-266594; CS-8023; MCULE-4145719408; NSC-401269; NCGC00247457-01; AC-12979; HY-30152; SMR001397046; 9-hydroxy-2H-furo[3,2-g]chromen-2-one; AB0021832; DB-045082; FT-0633974; N2298; ST50308995; W1288; 9-Hydroxy-7H-furo[3,2-g]chromen-7-one #; A14771; C00841; Q4021722; W-201757; 9-Hydroxy-7H-furo[3,2-g][1]benzopyran-7-one, 9CI; 5-Benzofuranacrylic acid, 6,7-dihydroxy-, .delta.-lactone; 5-Benzofuranacrylic acid, 6,7-dihydroxy-, gamma-lactone (7CI); 2-Propenoic acid,7-dihydroxy-5-benzofuranyl)-, .delta.-lactone; 6-(3,4-Dichlorophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole; 2-Propenoic acid, 3-(6,7-dihydroxy-5-benzofuranyl)-, .delta.-lactone